west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "拉莫三嗪" 11 results
  • 拉莫三嗪致Stevens-Johnson综合征一例

    Release date:2016-08-26 11:31 Export PDF Favorites Scan
  • 拉莫三嗪致重症多形红斑综合征护理一例

    Release date:2016-09-08 09:12 Export PDF Favorites Scan
  • Curative effect of levetiracetam combined with lamotrigine and sodium valproate postoperative patients with temporal lobe epilepsy

    ObjectiveTo compare the curative effect of levetiracetam combined with lamotrigine and sodium valproate on postoperative patients with temporal lobe epilepsy. MethodsA total of 186 postoperative patients with temporal lobe epilepsy during August 2012 to August 2014 in our hospital were divided into levetiracetam combined with lamotrigine group (n=98), and sodium valproate group (n=88) based on postoperative different antiepileptic drugs treatment. Antiepileptic treatment were followed up for 12~48 months.Curative effect and adverse reaction were observed. Reservation rates and incidence rates of adverse reaction were calculated in the two groups. ResultsIn levetiracetam combined with lamotrigine group, EngelⅠratio was 72.4%(71), EngelⅡratio was 17.3%(17), EngelⅢratio was 7.1%(7), and EngelⅣratio was 3.2%(3);in sodium valproate group, EngelⅠratio was 67.0%(59), EngelⅡratio was 21.6%(19), EngelⅢratio was 9.1%(8), and EngelⅣratio was 2.3%(2), and the difference was not statistically significant in the same grade of two groups (P > 0.05).Reservation rate and incidence rate of adverse reaction in levetiracetam combined with lamotrigine group were 90.8%(89) and 15.3%(15) respectively.While those in sodium valproate group were 80.7%(71) and 36.4%(32) respectively.The differences were statistically significant between the two groups (P < 0.05). ConclusionsLevetiracetam combined with lamotrigine treatment on postoperative patients with temporal lobe epilepsy may have better curative effects than sodium valproate treatment, and levetiracetam combined with lamotrigine has its advantage in reservation rate and less adverse reaction.

    Release date: Export PDF Favorites Scan
  • Effect of valproic acid coadministred with lamotrigine on epileptic patients' ammonia

    ObjectiveTo investigate the effect of valproic acid (VPA) coadministred with lamotrigine (LTG) on epileptic patients' ammonia and evaluate the influencing factors of elevated blood ammonia in epileptic patients.MethodsA retrospective analysis of clinical data from 146 patients with epilepsy (including newly diagnosed epilepsy patients) who were admitted to the Seventh Affiliated Hospital of Sun Yat-Sen University from May 2018 to April 2020 was performed. The patients were divided into no antiepileptic drug group (group A), VPA group only (group B) and VPA combined LTG group (group C), and the concentration of the blood ammonia of the patients were analyzed.ResultThe average ammonia levels in groups A, B and C were (18.14±1.19), (25.89±0.87) and (36.60±4.34) μmol/L, and the incidence of blood ammonia higher than normal were 2.77%, 8.89% and 20.0%, respectively.The difference between group B and group A and group C were statistically significant (P<0.05), the difference between group C and group A was statistically significant (P<0.05).ConclusionPatients with epilepsy who use VPA were at increased risk of blood ammonia and LTG can increase ammonia in epileptic patients who were treated with VPA. So when VPA was combined with LTG, more attention should be paid to ammonia of patient to avoid adverse reactions.

    Release date:2020-09-04 03:06 Export PDF Favorites Scan
  • 新型抗癫痫药物在控制孕期痫性发作的效能

    评估新型抗癫痫药物(AEDs)——拉莫三嗪、托吡酯与左乙拉西坦在患者妊娠期中控制痫性发作的效能。分析在澳大利亚登记数据库中应用AEDs控制痫性发作的癫痫患者中1 534例次患者妊娠的数据。在澳大利亚癫痫登记的数据中,接受单种AED治疗的1 111例次妊娠的患者中,妊娠期使用左乙拉西坦控制发作的患者的痫性发作控制率与服用传统AEDs如卡马西平、丙戊酸的发作控制率相近;优于拉莫三嗪、托吡酯在孕期的发作控制率。左乙拉西坦作为控制癫痫患者的妊娠期发作的药物有应用前景。

    Release date: Export PDF Favorites Scan
  • Efficacy and aging comparative study of different doses and sources of lamotrigine on cortex convulsive threshold in electrical stimulated rats

    Objective Using cortex convulsions threshold detector and electrical stimulation in rats cortex convulsions threshold model, compare the efficacy and aging of domestic lamotrigine (LTG) and imported LTG. Methods Electrical stimulation convulsions threshold model in rats after stability, 40 rats were randomly divided into A、B、C、D groups,AandBgroup were divided into three different dose groups: domestic LTG low dose (12.5 mg/kg/d), middle dose (25 mg/kg·d), high dose group (37.5 mg/kg·d); imported LTG low doses (12.5 mg/kg·d), middle dose (25 mg/kg·d), high dose group (37.5 mg/kg·d); Carbamazepine middle dose group (72 mg/kg·d); the control group (normal saline 2 ml/time). Recording electrical stimulation in rats cortex convulsions threshold model after administration, compare the differences before and after the administration. Results Three different dose groups of domestic LTG and imported LTG all hadahigher level of electrical stimulation cortex convulsions threshold, and showedadose-response relationship. Onset time of LTG after administration was 1 to 2 hours, peak time was 3 to 4 hours, maintaining time was 8 to 10 hours. Conclusion LTG can improve cortex convulsions threshold in the electrical stimulated rats, there was no significant difference with carbamazepine, and showedadose-response relationship; Repeat dosing for 4 days, both domestic and imported LIG can maintain effective anticonvulsive effect, the efficacy and the aging of two groups of LTG have no significant difference (P>0.05).

    Release date: Export PDF Favorites Scan
  • Clinical analysis of lamotrigine-related embryo damage and abortion

    ObjectiveTo discuss the risk of abortion related to lamotrigine (LTG) and its safety profile during pregnancy. MethodsRetrospectively studied pregnant women in our epilepsy clinics who took LTG from 2011 to 2015 as monotherapy and experienced embryo damage or abortion. Here, we present an extensive review of related literatures regarding possible mechanisms, clinical features and safty of LTG during pregnancy. ResultsIn our study, fourty-five pregnancies were administered monotherapy LTG, and three of these patients suffered embryo damage. ConclusionsAlthough LTG is considered safe for pregnant women and the embryo or fetus,it also has risk of embryo damage or abortion, which should be carefully considered before prescription. Using monotherapy and the lowest effective drug dose, monitoring LTG serum concentrations during pregnancy, supplementing folate administration before and after conception and conducting regular prenatal diagnostic tests might reduce the risk of abortion.

    Release date: Export PDF Favorites Scan
  • 暴露于新型抗癫痫发作药物后儿童神经发育结果的系统综述

    由于孕期暴露于某些传统的抗癫痫发作药物(Anti-seizure medications,ASMs)与儿童较差的神经发育有关,因此在整个妊娠期间使用新型ASMs的情况有所增加。本研究旨在阐明子宫内暴露于这些新型ASMs对儿童神经发育的影响。对MEDLINE、Embase、Web of Science、Cumulative Index to Nursing and Allied Health Literature Plus和PsycINFO进行了系统检索,结果仅限于2000年后发表的英文文章。调查宫内暴露于新型ASMs后神经发育结果的研究,纳入评价的药物包括:艾司利卡西平、加巴喷丁、拉考沙胺、拉莫三嗪、左乙拉西坦、奥卡西平、吡仑帕奈、托吡酯和唑尼沙胺,最终确定了35份发表的相关研究,并进行了描述性整合。方法学质量不统一,其不同的优势/劣势归因于研究设计。大多数研究观察了暴露于拉莫三嗪后其对儿童神经发育的并没有显著影响。左乙拉西坦的高质量研究相对较少,迄今为止未得到结论。托吡酯、加巴喷丁和奥卡西平的数据非常有限,无法得出确切的结论。令人担忧的是,尚无关于艾司利卡西平、拉考沙胺、吡仑帕奈或唑尼沙胺的研究。到目前为止,暴露于某些新型ASMs(如拉莫三嗪和左乙拉西坦)似乎并未影响神经发育的特定方面,但需要在不同的神经发育方面和剂量水平上进行进一步的研究。由于缺乏数据,无法确定新型ASMs的安全性,这些尚待进一步研究。

    Release date:2023-01-04 02:32 Export PDF Favorites Scan
  • Influencing factors of plasma concentration of lamotrigine in the treatment of epilepsy in children: a systematic review

    ObjectiveTo systematically review the factors influencing plasma concentration of lamotrigine (LTG) in the treatment of epilepsy in children.Methods Databases including PubMed, EMbase, The Cochrane Library, CNKI, WanFang Data, VIP and CBM were electronically searched to collect clinical studies on the factors influencing plasma concentration of LTG in the treatment of epilepsy in children from database inception to December 2020. Two researchers independently screened the literature, extracted data, and assessed the risk of bias of the included studies. A systematic review was then performed to analyze the factors influencing plasma concentration of LTG in the treatment of epilepsy in children. ResultsA total of 21 studies were included. The results of systematic review suggested that dosage and some combination drugs (valproic acid, carbamazepine, phenytoin sodium, topiramate, ethosuximide, rufinamide, fluoxetine, clonazepam, clobazam and ethinylestradiol) were potential factors influencing LTG concentration. Four gene polymorphisms (UGT1A4 142T>G, UGT1A4 219C>T, UGT1A4 163G>A, and OCT1 M408V A>G), age, weight, sex, and combination drugs (phenobarbital and levetiracetam) might affect the plasma concentration of LTG in children. The effects of oxcarbazepine, 16 gene polymorphisms (UGT1A4 *3 T>G, UGT2B7 211G>T, UGT2B7 372A>G, UGT2B7 735A>G, UGT2B7 801T>A, UGT2B7 802C>T, UGT2B7 161C>T, SCN1A IVS591G>A, SCN2A c.56G>A, SCN2A c.59G>A, MDR1 1236 C>T, MDR1 2677 G>T/A, MDR1 3435 C>T, SLC22A1 1022C>T, ABCB1 3435 C>T and ABCB1 1236C>T), ketogenic diet, and ethnicity (Uygur/Han) on the plasma concentration of LTG in children were not found. Conclusion The plasma concentration of LTG in the treatment of epilepsy in children is affected by many factors, and more high-quality prospective studies should be carried out to further clarify the factors influencing the plasma concentration of LTG in children.

    Release date:2022-05-31 01:32 Export PDF Favorites Scan
  • 拉莫三嗪致Stevens-Johnson综合征一例

    Release date: Export PDF Favorites Scan
2 pages Previous 1 2 Next

Format

Content